Outlook Therapeutics
OTLK
OTLK
14 hedge funds and large institutions have $1.53M invested in Outlook Therapeutics in 2019 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
29% less capital invested
Capital invested by funds: $2.15M → $1.53M (-$618K)
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$293K | |
| 2 | +$83K | |
| 3 | +$82K | |
| 4 |
PWMG
Prestige Wealth Management Group
Flemington,
New Jersey
|
+$9K |
| 5 |
AG
Advisor Group
Phoenix,
Arizona
|
+$5K |
Top Sellers
| 1 | -$1.39M | |
| 2 | -$100K | |
| 3 | -$57K | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$17.3K |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$15K |